theophylline and iomeprol

theophylline has been researched along with iomeprol in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Classen, M; Hennig, M; Huber, W; Ilgmann, K; Lutilsky, L; Page, M; Schipek, C; Schömig, A; Schweigart, U; Seyfarth, M; Valina, C; Wacker, A1
Eckel, F; Fritsch, R; Hamar, P; Heemann, U; Hennico, R; Hennig, M; Huber, W; Meining, A; Rosenbrock, H; Saur, D; Schenk, C; Schmelz, R; Schmid, RM; Sennefelder, A; Wacker, A; Weiss, W1

Trials

2 trial(s) available for theophylline and iomeprol

ArticleYear
Effectiveness of theophylline prophylaxis of renal impairment after coronary angiography in patients with chronic renal insufficiency.
    The American journal of cardiology, 2003, May-15, Volume: 91, Issue:10

    Topics: Adenosine; Aged; Contrast Media; Coronary Angiography; Creatinine; Endpoint Determination; Female; Humans; Iopamidol; Kidney Diseases; Kidney Failure, Chronic; Male; Predictive Value of Tests; Prospective Studies; Regression Analysis; Risk Factors; Theophylline; Treatment Outcome; Vasodilator Agents

2003
Prophylaxis of contrast material-induced nephropathy in patients in intensive care: acetylcysteine, theophylline, or both? A randomized study.
    Radiology, 2006, Volume: 239, Issue:3

    Topics: Acetylcysteine; Adult; Aged; Aged, 80 and over; Blood Urea Nitrogen; Contrast Media; Creatinine; Critical Care; Drug Combinations; Female; Follow-Up Studies; Free Radical Scavengers; Humans; Iopamidol; Kidney Diseases; Male; Middle Aged; Phosphodiesterase Inhibitors; Prospective Studies; Protective Agents; Risk Factors; Theophylline; Time Factors

2006